Description of Collaborative Activity: |
The NIH-FDA Interagency Clinical Outcome Assessments Working Group is a chartered group. The purpose of the group is for the two agencies to work together strategically to foster science and processes related to the development and application of Clinical Outcome Assessments for use in medical product development and clinical and translational research to support regulatory science. |
NIH Participating Institutes/Centers/Office of the Director: |
CC, NCCAM, NCI, NHLBI, NIA, NIAMS, NICHD, NIDDK, NIMH, NINDS, OD |